Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: Correlation with the integral dose restricted to the irradiated fields

被引:61
作者
Nguyen, France [1 ,2 ]
Rubino, Carole [1 ,2 ]
Guerin, Sylvie [1 ,2 ]
Diallo, Ibrahima [1 ,2 ]
Samand, Akthar [1 ,2 ]
Hawkins, Mike [3 ]
Oberlin, Odile [4 ]
Lefkopoulos, Dimitri [5 ,6 ]
De Vathaire, Florent [1 ,2 ]
机构
[1] Inst Gustave Roussy, INSERM, U605, F-94805 Villejuif, France
[2] Univ Paris 09, Villejuif, France
[3] Univ Birmingham, Ctr Childhood Canc Survivor Studies, Birmingham, W Midlands, England
[4] Inst Gustave Roussy, Dept Paediat, Villejuif, France
[5] Inst Gustave Roussy, Dept Med Phys, Villejuif, France
[6] Inst Gustave Roussy, Dept Radiotherapy, F-94805 Villejuif, France
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 70卷 / 03期
关键词
integral dose; radiotherapy; second malignant neoplasm; childhood cancer; cohort study;
D O I
10.1016/j.ijrobp.2007.10.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: After successful treatment of cancers in childhood, the occurrence of second malignant neoplasm (SMN) came to the fore. Few studies have considered the relationship between the radiation dose received and the risk of developing an SMN. To take into account the heterogeneity of the dose distribution so as to evaluate the overall risk of an SMN after a childhood cancer, we therefore focused on the integral dose restricted to the irradiated fields. Methods and Materials: The study was performed in a cohort of 4,401 patients who were 3-year survivors of all types of childhood cancer treated between 1947 and 1986 in France and Great Britain. For each patient, the integral dose was estimated for the volume inside the beam edges. Results: We found a significant dose-response relationship between the overall risk of an SMN and the estimated integral dose. The excess relative risk for each incremental unit of the integral dose was only 0.008 in a linear model and 0.017 when a negative exponential term was considered, when adjusted for chemotherapy. The risk of SMN occurrence was 2.6 times higher in the case of irradiation. However among patients who had received radiotherapy, only those who had received the highest integral dose actually had a higher risk. Conclusions: The integral dose in our study cannot be considered as a good predictor of later risks. However other studies with the same study design are obviously needed to evaluate the use of the integral dose as a tool for decision making concerning different radiotherapy techniques. (C) 2008 Elsevier Inc.
引用
收藏
页码:908 / 915
页数:8
相关论文
共 36 条
[1]  
[Anonymous], 1993, EPICURE USERS GUIDE
[2]  
Colonna M, 2000, INT J CANCER, V87, P301, DOI 10.1002/1097-0215(20000715)87:2<301::AID-IJC24>3.0.CO
[3]  
2-Y
[4]   Second malignant neoplasms after a first cancer in childhood:: temporal pattern of risk according to type of treatment [J].
de Vathaire, F ;
Hawkins, M ;
Campbell, S ;
Oberlin, O ;
Raquin, MA ;
Schlienger, JY ;
Shamsaldin, A ;
Diallo, I ;
Bell, J ;
Grimaud, E ;
Hardiman, C ;
Lagrange, JL ;
Daly-Schveitzer, N ;
Panis, X ;
Zucker, JM ;
Sancho-Garnier, H ;
Eschwège, F ;
Chavaudra, J ;
Lemerle, J .
BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) :1884-1893
[5]   Thyroid carcinomas after irradiation for a first cancer during childhood [J].
de Vathaire, F ;
Hardiman, C ;
Shamsaldin, A ;
Campbell, S ;
Grimaud, E ;
Hawkins, M ;
Raquin, M ;
Oberlin, O ;
Diallo, I ;
Zucker, JM ;
Panis, X ;
Lagrange, JL ;
Daly-Schveitzer, N ;
Lemerle, J ;
Chavaudra, J ;
Schlumberger, M ;
Bonaïti, C .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (22) :2713-2719
[6]  
DEVATHAIRE F, 1995, CR ACAD SCI III-VIE, V318, P483
[7]   ROLE OF RADIOTHERAPY AND CHEMOTHERAPY IN THE RISK OF 2ND MALIGNANT NEOPLASMS AFTER CANCER IN CHILDHOOD [J].
DEVATHAIRE, F ;
FRANCOIS, P ;
HILL, C ;
SCHWEISGUTH, O ;
RODARY, C ;
SARRAZIN, D ;
OBERLIN, O ;
BEURTHERET, C ;
DUTREIX, A ;
FLAMANT, R .
BRITISH JOURNAL OF CANCER, 1989, 59 (05) :792-796
[8]   Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy [J].
Diallo, I ;
Lamon, A ;
Shamsaldin, A ;
Grimaud, E ;
deVathaire, F ;
Chavaudra, J .
RADIOTHERAPY AND ONCOLOGY, 1996, 38 (03) :269-271
[9]  
Dorr Wolfgang, 2002, J Radiol Prot, V22, pA117, DOI 10.1088/0952-4746/22/3A/321
[10]  
Garwicz S, 2000, INT J CANCER, V88, P672, DOI 10.1002/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO